NOTRELOAD AI
  • NOTRELOAD AI
  • Stocks BUZZ.
  • #TrumpTrade
  • 24-HOUR Pass →
  • Invest ↗
Sign in Subscribe

Mobix Labs Scores Major U.S. Navy Order for Tomahawk Missile Components as Production Surges

Mobix Labs secures significant order for Tomahawk missile components as U.S. Navy ramps up production—stock surges on defense demand boost.

Mobix Labs Scores Major U.S. Navy Order for Tomahawk Missile Components as Production Surges
Credit: Craig Walton
Already have an account? Sign in.
03/03/2026 · 9:20 AM
MOBX
/ Read more

Feed↓

Trump Team Eyes Strict Limit: Only 75,000 H200 & MI325 Chips per Chinese Firm
03/03/2026 · 10:46 AM

Trump Team Eyes Strict Limit: Only 75,000 H200 & MI325 Chips per Chinese Firm

The US is considering capping AI chip exports like Nvidia's H200 and AMD's MI325 to just 75,000 units per Chinese company. This news is pressuring stocks amid ongoing trade tensions and global market worries.

/ Subscriber only
TransCode Secures Next-Generation Oncolytic Immunotherapy License – Eyes Multi-Billion Dollar Bladder Cancer Market
03/03/2026 · 10:02 AM

TransCode Secures Next-Generation Oncolytic Immunotherapy License – Eyes Multi-Billion Dollar Bladder Cancer Market

TransCode Therapeutics (RNAZ) announces an exclusive license for advanced cancer immunotherapy tech from Unleash, targeting hard-to-treat bladder cancer and more, in an all-stock deal to expand their pipeline.

/ Subscriber only
Theravance Biopharma’s Phase 3 Failure Triggers Cost Cuts and Sale Exploration
03/03/2026 · 8:55 AM

Theravance Biopharma’s Phase 3 Failure Triggers Cost Cuts and Sale Exploration

Theravance Biopharma's ampreloxetine failed its Phase 3 CYPRESS study for nOH in MSA. Company winds down program, cuts costs ~60%, focuses on YUPELRi cash flow, and speeds up strategic alternatives review to maximize shareholder value.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe